Goldman Sachs Group »

Kempharm shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Kempharm (ZVRA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Kempharm

Tip: Access up to 7 years of quarterly data

All positions including Kempharm held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kempharm by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $234k 36k 6.55
2023-09-30 $146k 30k 4.82
2023-06-30 $187k 37k 5.10
2023-03-31 $181k 33k 5.50
2022-12-31 $107k 23k 4.59
2022-06-30 $344k 77k 4.45
2022-03-31 $766k 152k 5.03
2021-12-31 $1.7M 191k 8.71
2021-09-30 $1.6M 169k 9.33
2021-03-31 $312k 34k 9.20